Delayed myocardial enhancement MRI is a highly valuable but non-specific imaging technique that is ancillary in the diagnosis of a variety of diseases including myocardial viability, cardiomyopathy, myocarditis and other infiltrative myocardial processes. The lack of specificity stems from the wide variety of differential diagnoses that may present with overlapping patterns of delayed enhancement. Many of these differential diagnoses have been presented and discussed in this article.
PICTORIAL REVIEW

Introduction
There is a different pattern of early and delayed contrast accumulation in normal and injured myocardial tissue, which is exploited for myocardial perfusion imaging and delayed imaging for the diagnosis of myocardial scar. Ischemic myocardium typically shows delayed time to peak enhancement and lower maximal peak enhancement compared to normal myocardium. Myocardial scar demonstrates increased accumulation of contrast agent in combination with delayed washout over time, which manifests as abnormal myocardial contrast enhancement on delayed imaging [ Figure  1 ].
Delayed myocardial enhancement MR imaging is currently used for the diagnosis of myocardial involvement in a variety of cardiac and non-cardiac disorders. Late gadolinium enhancement cardiac magnetic resonance (MR) imaging was introduced in 1989 [1] for the identification of infarcted myocardial tissue. The technique was described in more detail in 1993 [2] and since became a routine sequence in cardiac MR imaging.
The clinical use of delayed myocardial enhancement MR imaging is most commonly performed for evaluation of a myocardium at risk and for determination of the treatment options. In cases of ischemic cardiomyopathy, as in other cases, it is used to evaluate the presence of a scar. An ischemic myocardium without a scar is salvable by reperfusion therapy. A magnetic resonance water sequence imaging (T2) shows accumulation of extra-cellular fluid in a reversible injured myocardium; however, in an irreversible tissue with fibrosis T2 is negative. Delayed contrast enhanced MRI with a Gadolinium based agent may differentiate between acute and chronic myocardial injury, a sequence that helps the decisionmaking cardiologist to determine the treatment options and to assess the risk stratification [3] .
Technique
A number of studies have demonstrated the effectiveness of a segmented inversion recovery fast gradient echo sequence for differentiating injured from normal myocardium with a very high signal intensity difference between diseased and normal myocardial tissue [4, 5] . The images are typically acquired 10 to 25 minutes following the administration of gadolinium-based contrast agent. The underlying concept of this technique is based on the delayed washout of contrast agent from an area of injured myocardium compared to the rapid washout of the contrast agent from normal myocardium. An inversion recovery signal is applied to "null" the signal of normal myocardium in order to maximize the contrast between affected and normal myocardium [6] . The data acquisition time is usually variable and ranges from approximately 140 -300 ms depending on the patient's heart rate. The images are typically acquired during mid-diastole when the heart is relatively motionless. Immediately after the onset of the R wave trigger of the recorded EKG, there is a short delay before the application of the 180 degrees inversion pulse. Following this inversion pulse, there is second delay period, which varies, based on the time post contrast administration for optimal nulling of the signal of normal myocardium [6] .
This strategy is most effective in cases when regional differences exist in gadolinium retention, such as in infarcted tissue. This method is less effective in diseases that affect the entire myocardium without regional variation such as amyloidosis. In amyloidosis the entire myocardium tends to be involved in a circumferential manner and the contrast kinetics are similarly altered; the deposition of the abnormal protein typically occurs in a circumferential manner starting in the endocardium and extending through the myocardium in a transmural fashion. Therefore, choosing the optimal T1 time for the inversion recovery pulse is difficult. In cardiac amyloidosis the gadolinium is typically extracted faster from normal myocardial tissue compared to the blood pool. Therefore the optimal inversion time to null the signal of the myocardium should be shorter than in the typical case of myocardial infarction.
Recent developments such as the Phase Sensitive Inversion Recovery (PSIR) sequence facilitate the parameter setting for delayed enhancement imaging and make it less dependent on the precise selection of the inversion time for myocardial signal nulling. The sequence removes the background phase while preserving the signal of the desired magnetization during inversion recovery [7] .
Types of delayed enhancement
Delayed enhancement can typically be seen in postischemic myocardial infarction (scar). Ischemic infarction typically involves the subendocardial layer due to its distance from the coronary arteries located in the epicardium. If the delayed enhancement involves myocardial layers other than the subendocardium (i.e. midwall or epicardial), different nonischemic myocardial diseases have to be considered. The pattern of the enhancement is helpful for the differential diagnosis and distinguishing an ischemic etiology from nonischemic causes [8, 9] . The most common disease entities that may cause delayed enhancement are summarized in table 1 according to the myocardial layer that the enhancement most likely involves. It needs to be emphasized, however, that the enhancement pattern is not always specific for a particular disease. Therefore the radiological diagnosis should always involve clinical and other ancillary findings.
Ischemic cardiomyopathy
In the setting of regional myocardial dysfunction caused by ischemic cardiomyopathy, the amount of myocardial tissue exhibiting delayed enhancement is inversely proportional to the likelihood of recovery of systolic thickening that occurs after coronary artery revascularization [10] . Delayed enhancement identifies infarction or fibrotic tissue, while absence of enhancement indicates viable myocardium likely to improve following revascularization [11] .
The pattern of the delayed enhancement will reflect the vascular distribution of the affected vascular territory. The location of delayed enhancement within the myocardium will show either subendocardial or transmural enhancement [12, 13] [figures 2 -4].
Non-Ischemic Causes
Specific Cardiomyopathy
The distribution pattern of delayed enhancement in different entities that causes cardiomyopathy is typically different from the subendocardial delayed enhancement following a coronary territory found in myocardial infarction. The affected areas may include papillary muscles [ figure 5 ] (sarcoid), the mid-myocardium (Anderson-Fabry disease [ figure 6 ], myocarditis, Becker muscular dystrophy) and the global sub-endocardium (systemic sclerosis, Loeffler's endocarditis, amyloid, Churg-Strauss). Delayed myocardial enhancement can be observed in Glycogen storage disease [14] , although a rare finding [15] .
Sarcoidosis
Sarcoidosis is an idiopathic disease characterized by the presence of non-caseating granulomas in the involved organ system. Systemic sarcoidosis affects the respiratory system or mediastinal lymph nodes in more than 90% of cases, but any organ system can be involved. Cardiac involvement is common and significantly alters the patient's prognosis. Delayed enhanced MRI is considered a sensitive marker of cardiac involvement in patients with sarcoidosis [16] . Cardiac involvement generates symptoms in only 5% of patients with cardiac involvement and has been shown to be present as noncaseating granulomatous infiltration of the myocardium at autopsy in 20-50% of patients [17] . In the advanced postinflammatory stage, delayed enhancement is seen, reflecting replacement fibrosis with higher interstitial concentration of contrast material. This reflects a nonspecific scar that may be associated with myocardial thinning and segmental contraction abnormalities. The delayed enhancement pattern is usually patchy or demonstrates longitudinal striae in the mid wall and/or subepicardium [18, 19, 20] [ figure 7 ]. This pattern is more commonly observed in the basal septum or left ventricular wall [9] . In the presence of myocardial scar or granuloma the observed delayed enhancement is often patchy or nodular appearance [20, 21] .
Amyloidosis
Amyloidosis is characterized by the build up of a substance known as amyloid in parenchymal organs and soft tissues. Amyloid is formed from the breakdown of normal or abnormal proteins. The amyloid that is derived from these breakdown products accumulates between the cells of one or more of the body's organ systems and may interfere with organ function. Cardiac involvement is frequent in systemic amyloidosis of immunoglobulin light chain and transthyretin types and is a major determinant of treatment options and prognosis [22] . Accumulation of these various proteins in the insoluble fibrillar amyloid conformation occurs principally in the myocardial interstitium, leading to diastolic dysfunction and eventually to restrictive cardiomyopathy [23, 24, 25] . In cardiac amyloidosis, cardiac magnetic resonance imaging may show a characteristic pattern of global subendocardial late enhancement coupled with abnormal myocardial and bloodpool gadolinium kinetics [25] [ figure 8 ]. In cardiac amyloid disease, the deposition of the abnormal protein typically occurs in a circumferential manner starting in the endocardium and then extending to the myocardium in a transmural fashion. The null point of the myocardium is typically reached before the blood pool is nulled (T1 of the myocardium is shorter than that of the blood), therefore the inversion time (TI) should be adjusted accordingly [7] .
Hypertrophic Cardiomyopathy (HOCM)
HOCM is a genetic myocardial disorder with an autosomal dominant transmission. It has a prevalence of 1:500 and may lead to lethal arrhythmias in younger adults. It is characterized by left ventricular hypertrophy, which most prominently affects the septum with a diastolic thickness exceeding 15 mm. The septal thickening leads to left ventricular outflow tract obstruction in 25% of cases often accompanied by a systolic anterior motion of the mitral valve complex. Delayed enhancement is commonly intramural with a linear and patchy pattern often observed in the interventricular septum [9, 26, 27] [ figure 9 ].
Hypereosinophilic Syndrome
Hypereosinophilic syndrome is a myoproliferative disorder characterized by persistent eosinophilia that is associated with damage to multiple organs. This is a form of myocarditis with eosinophilic infiltration of the myocardium (Loeffler's endomyocarditis). This form of myocardial disease has three stages: acute necrotic; thrombotic-necrotic; late fibrotic. Detection during the acute phase is often difficult, as the patient may not present with specific cardiac symptoms; electrocardiography (EKG) or echocardiography may be unremarkable. Therefore, delayed enhancement cardiac MRI is a valuable non-invasive diagnostic tool for the demonstration of myocardial fibrosis and subendocardial delayed enhancement [9, 28] 
Dilated Cardiomyopathy
Dilated cardiomyopathy can be idiopathic or secondary to other disease entities including myocarditis, Duchenne or Becker muscular dystrophies, and pregnancy. It is defined as a left ventricular end-diastolic diameter of more than 55mm. Delayed enhancement typically demonstrates a patchy longitudinal mid-wall pattern without subendocardial involvement [9, 29, 30] .
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Findings may include right ventricular dilatation, regional wall thinning, hypertrophy, and aneurysms. ARVC can lead to ventricular tachycardia and sudden death. Fatty and fibro-fatty variants of ARVC exist. On delayed enhancement the fatty variant is typically identified by myocardial fatty infiltration without ventricular wall thinning, while the fibro-fatty variant demonstrates right ventricular wall thinning. The sub-tricuspid area, infundibulum, and right ventricular apex are most commonly identified as abnormal on MRI [9, 31, 32] . (4) myotonic dystrophy. Duchenne muscular dystrophy and Becker muscular dystrophy are X-linked disorders affecting the synthesis of dystrophin, a large, sarcolemmal protein that is absent in Duchenne muscular dystrophy and reduced in amount or abnormal in size in Becker muscular dystrophy patients. In several forms of muscular dystrophy, cardiac dysfunction occurs, and cardiac disease may even be the predominant manifestation of the underlying genetic myopathy.
Muscular Dystrophy
Common findings on delayed enhancement images involve the mid-wall and subepicardium due to myocardial fibrosis. The imaging findings may be global or regional, affecting the inferolateral, anterolateral, anterior, and/or septal walls [33,34] [ figure 12 ].
Conclusion
There are two main entities for delayed myocardial enhancement: ischemic and non-ischemic. Ischemic cardiomyopathy typically presents with involvement of the subendocardium, while non-ischemic causes do not necessarily involve the subendocardium. The non-ischemic category includes a number of differential diagnoses for delayed enhancement, many of which demonstrate overlapping imaging characteristics.
Myocardial delayed enhancement is a highly valuable tool for the diagnosis of fibrosis, scar or nonviable myocardium, whether the full thickness of the myocardial segment is involved or just one of its layers. The finding is nonspecific and the inclusion of clinical information is essential in the diagnostic decision process. Often the definition of type, pattern and extent of delayed enhancement is useful for disease prognosis and therapeutic management decision. Global endocardial
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Systemic sclerosis
Cardiac manifestations can affect all structures of the heart, and may result in pericardial effusion, arrhythmias, conduction system defects, valvular impairment, myocardial ischemia, myocardial hypertrophy and heart failure Global endocardial
Churg-Strauss Syndrome
Symptoms consistent with cardiomyopathy as a consequence of vasculitisrelated ischemia affecting small myocardial vessels and coronary arteries, or from eosinophilic or granulomatous myocardial infiltration
Global endocardial
Dilated Cardiomyopathy
Ventricular enlargement and systolic dysfunction. Disease progression may lead to mitral and tricuspid valve regurgitation and eventually heart failure Mid wall
Hypertrophic Cardiomyopathy
Thickening of the myocardium, most commonly affecting the septum. This may lead to left ventricular outflow obstruction and eventually heart failure Mid wall
Duchenne's Muscular Dystrophy
Myocardial damage likely related to mechanical stress imposed on a metabolically and structurally abnormal myocardium. Fibrosis commonly occurs in the inferolateral wall Mid wall and/or subepicardial, typically inferolateral wall
Becker's Muscular Dystrophy
Myocardial damage has been postulated to result from mechanical stress imposed on a metabolically and structurally abnormal myocardium. Fibrosis commonly occurs in the inferolateral wall.
Mid wall, typically inferolateral wall
Myocarditis
Cardiac manifestation may result in chest pain, fever, sweats, chills, dyspnea, palpitations, syncope, heart failure, and sudden death Mid wall and/or subepicardial
Anderson-Fabry Disease
Clinical disease manifestations include left-ventricular myocardial hypertrophy, valvular thickening, and ectasia of the ascending aorta and conduction abnormalities. Myocardial fibrosis is typically an end-stage manifestation.
Mid wall
Sarcoidosis
Symptoms of cardiac sarcoidosis may include congestive heart failure, conduction abnormalities, atrial and ventricular arrhythmias, and sudden death. In its early stages, sarcoid is an active inflammatory disorder that may cause myocardial edema, which may progress to fibrosis Mid wall and/or subepicardial 
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